Janine Hass
Adult Health · Cape Coral, FLNPI 1558600676
Payments from drug & device makers
Across 48 payments — averaging $22.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$465
- Boston Scientific$342
- Scilex Pharmaceuticals Inc.$41
- Vertos Medical, Inc.$35
- Takeda Pharmaceuticals U.S.A., Inc.$32
- Relievant Medsystems, Inc.$24
- plus $120 from 8 others
What the payments were for
- Food & beverage$1,059100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 26 | $465 |
| Boston Scientific | 9 | $342 |
| Scilex Pharmaceuticals Inc. | 2 | $41 |
| Vertos Medical, Inc. | 1 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Relievant Medsystems, Inc. | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Coastal Medical Technologies LLC | 1 | $15 |
| Spinal Simplicity, LLC | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Fidia Pharma USA Inc. | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Redhill Biopharma Inc. | 1 | $12 |
How this compares
$1,059 in reported general payments places this provider in the 65th percentile of 2,237 adult health providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 104 | $8,640 |
| Gabapentin | 293 | $5,087 |
| Cyclobenzaprine Hcl | 151 | $2,690 |
| Tizanidine Hcl | 128 | $2,261 |
| Celecoxib | 67 | $1,646 |
| Methocarbamol | 59 | $1,111 |
| Baclofen | 60 | $1,018 |
| Diclofenac Sodium | 28 | $635 |
| Duloxetine Hcl | 52 | $515 |
| Topiramate | 22 | $178 |
| Methylprednisolone | 16 | $127 |
| Meloxicam | 33 | $88 |
Paid to pharmacies, not to this prescriber.
Other adult health in Cape Coral
- Patricia PagnottaMaitland$441K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Alejandro Dela CruzOrlando$44K
- Cynthia OteroMaitland$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.